During the past decade, Langeberg Clinical Trials conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Langeberg Clinical Trials" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "BioNTech SE" with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Regeneron Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Langeberg Clinical Trials" #1 collaborator was "Atea Pharmaceuticals, Inc." with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Langeberg Clinical Trials" are "COVID-19" (2 trials), "Chronic Idiopathic Constipation" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Influenza" (1 trials) and "Osteoarthritis, Hip" (1 trials). Many other conditions were trialed in "Langeberg Clinical Trials" in a lesser frequency.

Most popular intervention types in "Langeberg Clinical Trials" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Astegolimab" (1 trials), "BNT162b2" (1 trials), "BNT162b2 (B.1.1.529)" (1 trials) and "BNT162b2 (B.1.1.7 + B.1.617.2)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Langeberg Clinical Trials" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Langeberg Clinical Trials". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Langeberg Clinical Trials, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Langeberg Clinical Trials, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".